These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 33460661

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway.
    Han S, Lin F, Ruan Y, Zhao S, Yuan R, Ning J, Jiang K, Xie J, Li H, Li C, Rao T, Yu W, Xia Y, Zhou X, Cheng F.
    Int Immunopharmacol; 2021 Oct; 99():108022. PubMed ID: 34339961
    [Abstract] [Full Text] [Related]

  • 3. miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway.
    Zhao S, Li T, Li J, Lu Q, Han C, Wang N, Qiu Q, Cao H, Xu X, Chen H, Zheng Z.
    Diabetologia; 2016 Mar; 59(3):644-54. PubMed ID: 26687158
    [Abstract] [Full Text] [Related]

  • 4. MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway.
    Fu Q, Pan H, Tang Y, Rong J, Zheng Z.
    Cardiovasc Toxicol; 2021 Apr; 21(4):302-313. PubMed ID: 33638775
    [Abstract] [Full Text] [Related]

  • 5. Inhibiting microRNA-200a-3p attenuates pyroptosis via targeting the SIRT1/NF-κB/NLRP3 pathway in H2O2-induced HAEC.
    Liu J, Yan Y, Zheng D, Zhang J, Wang J.
    Aging (Albany NY); 2023 Oct 23; 15(20):11184-11200. PubMed ID: 37874693
    [Abstract] [Full Text] [Related]

  • 6. Rno-microRNA-30c-5p promotes myocardial ischemia reperfusion injury in rats through activating NF-κB pathway and targeting SIRT1.
    Chen J, Zhang M, Zhang S, Wu J, Xue S.
    BMC Cardiovasc Disord; 2020 May 20; 20(1):240. PubMed ID: 32434515
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of miR-181a attenuates sepsis-induced inflammation and apoptosis by activating Nrf2 and inhibiting NF-κB pathways via targeting SIRT1.
    Wu Z, Chen J, Zhao W, Zhuo CH, Chen Q.
    Kaohsiung J Med Sci; 2021 Mar 20; 37(3):200-207. PubMed ID: 33058411
    [Abstract] [Full Text] [Related]

  • 8. Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-κB pathway.
    Yang Y, Li L.
    J Drug Target; 2021 Apr 20; 29(4):420-429. PubMed ID: 33185125
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
    Abdolvahabi Z, Nourbakhsh M, Hosseinkhani S, Hesari Z, Alipour M, Jafarzadeh M, Ghorbanhosseini SS, Seiri P, Yousefi Z, Yarahmadi S, Golpour P.
    J Cell Biochem; 2019 Jun 20; 120(6):9356-9368. PubMed ID: 30520099
    [Abstract] [Full Text] [Related]

  • 10. PM2.5 Upregulates MicroRNA-146a-3p and Induces M1 Polarization in RAW264.7 Cells by Targeting Sirtuin1.
    Zhong Y, Liao J, Hu Y, Wang Y, Sun C, Zhang C, Wang G.
    Int J Med Sci; 2019 Jun 20; 16(3):384-393. PubMed ID: 30911272
    [Abstract] [Full Text] [Related]

  • 11. MiR-21 Regulates TNF-α-Induced CD40 Expression via the SIRT1-NF-κB Pathway in Renal Inner Medullary Collecting Duct Cells.
    Lin Q, Geng Y, Zhao M, Lin S, Zhu Q, Tian Z.
    Cell Physiol Biochem; 2017 Jun 20; 41(1):124-136. PubMed ID: 28214900
    [Abstract] [Full Text] [Related]

  • 12. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.
    Zhang QS, Liu W, Lu GX.
    J Biosci; 2017 Sep 20; 42(3):397-404. PubMed ID: 29358553
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-30a-5p Promotes Chronic Heart Failure in Rats by Targeting Sirtuin-1 to Activate the Nuclear Factor-κB/NOD-Like Receptor 3 Signaling Pathway.
    Wu YX, Xu RY, Jiang L, Chen XY, Xiao XJ.
    Cardiovasc Drugs Ther; 2023 Dec 20; 37(6):1065-1076. PubMed ID: 35488974
    [Abstract] [Full Text] [Related]

  • 14. Mir-141-3p Regulates Apoptosis and Mitochondrial Membrane Potential via Targeting Sirtuin1 in a 1-Methyl-4-Phenylpyridinium in vitro Model of Parkinson's Disease.
    Zheng Y, Dong L, Liu N, Luo X, He Z.
    Biomed Res Int; 2020 Dec 20; 2020():7239895. PubMed ID: 33204711
    [Abstract] [Full Text] [Related]

  • 15. miR-19a/b-3p promotes inflammation during cerebral ischemia/reperfusion injury via SIRT1/FoxO3/SPHK1 pathway.
    Zhou F, Wang YK, Zhang CG, Wu BY.
    J Neuroinflammation; 2021 May 29; 18(1):122. PubMed ID: 34051800
    [Abstract] [Full Text] [Related]

  • 16. Exosomal miR-22-3p derived from peritoneal macrophages enhances proliferation, migration, and invasion of ectopic endometrial stromal cells through regulation of the SIRT1/NF-κB signaling pathway.
    Zhang L, Li HH, Yuan M, Li D, Wang GY.
    Eur Rev Med Pharmacol Sci; 2020 Jan 29; 24(2):571-580. PubMed ID: 32016958
    [Abstract] [Full Text] [Related]

  • 17. Investigating the Function of MicroRNAs in Human Retinal Microvascular Endothelial Cells of Diabetic Retinopathy.
    Zeng Y, Cui Z, Chen J, Tang S.
    Methods Mol Biol; 2023 Jan 29; 2678():199-205. PubMed ID: 37326716
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
    Xia XY, Yu YJ, Ye F, Peng GY, Li YJ, Zhou XM.
    Neoplasma; 2020 Mar 29; 67(2):344-353. PubMed ID: 31973537
    [Abstract] [Full Text] [Related]

  • 19. Ginsenoside Rg1 promoted the wound healing in diabetic foot ulcers via miR-489-3p/Sirt1 axis.
    Huang L, Cai HA, Zhang MS, Liao RY, Huang X, Hu FD.
    J Pharmacol Sci; 2021 Nov 29; 147(3):271-283. PubMed ID: 34507636
    [Abstract] [Full Text] [Related]

  • 20. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
    He L, Wang Z, Zhou R, Xiong W, Yang Y, Song N, Qian J.
    Biomed Pharmacother; 2021 Jan 29; 133():110993. PubMed ID: 33220608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.